Correlation Between Halozyme Therapeutics and Arrowhead Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Halozyme Therapeutics and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Halozyme Therapeutics and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Halozyme Therapeutics and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Halozyme Therapeutics and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Halozyme Therapeutics with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Halozyme Therapeutics and Arrowhead Pharmaceuticals.
Diversification Opportunities for Halozyme Therapeutics and Arrowhead Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Halozyme and Arrowhead is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Halozyme Therapeutics and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Halozyme Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Halozyme Therapeutics are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Halozyme Therapeutics i.e., Halozyme Therapeutics and Arrowhead Pharmaceuticals go up and down completely randomly.
Pair Corralation between Halozyme Therapeutics and Arrowhead Pharmaceuticals
Given the investment horizon of 90 days Halozyme Therapeutics is expected to generate 1.61 times more return on investment than Arrowhead Pharmaceuticals. However, Halozyme Therapeutics is 1.61 times more volatile than Arrowhead Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 5,046 in Halozyme Therapeutics on August 28, 2024 and sell it today you would lose (267.00) from holding Halozyme Therapeutics or give up 5.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Halozyme Therapeutics vs. Arrowhead Pharmaceuticals
Performance |
| Timeline |
| Halozyme Therapeutics |
| Arrowhead Pharmaceuticals |
Halozyme Therapeutics and Arrowhead Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Halozyme Therapeutics and Arrowhead Pharmaceuticals
The main advantage of trading using opposite Halozyme Therapeutics and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Halozyme Therapeutics position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |